OrganOx was spun out from the University of Oxford in April 2008 and has developed the world’s first normothermic liver perfusion device, the Metra, approved for storage and transportation of human transplant livers.

The technology, which is also being developed for normothermic perfusion of transplant kidneys, has the potential to disrupt the transplant market, significantly increasing the supply of viable organs by overcoming several major limitations in existing methods. Data from the 220-patient European clinical was published in the prestigious academic journal Nature in 2Q 2018.

Visit website